<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Synterex ]]></title><description><![CDATA[Synterex is a clinical and regulatory consulting firm specializing in agile methodology, automation, and AI driven technologies.]]></description><link>https://www.synterex.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Mon, 09 Mar 2026 16:42:25 GMT</lastBuildDate><atom:link href="https://www.synterex.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Why AI Integration in Medical Writing Must Start with User Goals, Not Documents ]]></title><description><![CDATA[AI adoption in medical writing often begins in the wrong place. Many organizations start by automating document-centric workflows—focusing on templates, formats, and production speed—without first examining the purpose those documents serve. But documents do not make decisions. People do. Regulatory reviewers, sponsors, safety teams, and clinicians use documents as tools to support judgment, assess risk–benefit, and determine next steps.  When AI integration is treated as a way to generate...]]></description><link>https://www.synterex.com/post/ai-integration-in-medical-writing</link><guid isPermaLink="false">6981257c396306036ecdeb14</guid><category><![CDATA[Medical Writing & Pharma]]></category><category><![CDATA[Technology]]></category><pubDate>Mon, 09 Mar 2026 16:22:18 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/11062b_4bbeb076691b4370bc020616b5613edd~mv2.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[Fine-Tuning vs. Prompting: Teaching AI Medical Writing Systems What Matters ]]></title><description><![CDATA[One of the most common frustrations teams encounter when using AI for medical writing is the feeling that they’re constantly re-explaining their standards. The instinctive response is to write longer prompts. More detailed prompts. Carefully engineered prompts. But prompting isn’t memory—and it isn’t training. Understanding the difference between prompting and fine-tuning is critical if AI is going to become reliable rather than exhausting. Prompting Defines the Task, Not the System Prompting...]]></description><link>https://www.synterex.com/post/ai-medical-writing-systems</link><guid isPermaLink="false">69a6fd035f34dbe2951dbbe0</guid><category><![CDATA[Medical Writing & Pharma]]></category><pubDate>Tue, 03 Mar 2026 15:36:05 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/e65684_2c827723d4294fb3b9ff48732553d935~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[Tokenization: When One Word Becomes Many Problems in AI-Assisted Medical Writing ]]></title><description><![CDATA[If you’ve ever watched an AI tool do a solid job drafting a section—only to cut off a table, ignore an earlier definition, or unravel at the end—you’ve probably assumed the issue was the prompt.  Often, it isn’t.  In many cases, the underlying issue is tokenization, a foundational machine learning concept that directly affects how generative AI processes medical and regulatory documents. Tokenization determines how text is broken down, how much context an AI model can retain, and which parts...]]></description><link>https://www.synterex.com/post/tokenization-in-ai-assisted-medical-writing</link><guid isPermaLink="false">69864f9d2764679ea7115efa</guid><category><![CDATA[Medical Writing & Pharma]]></category><category><![CDATA[Technology]]></category><pubDate>Fri, 06 Feb 2026 20:47:12 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/e65684_2c827723d4294fb3b9ff48732553d935~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[From User Intent to Regulatory Output: Why AI Integration Starts with Goals, Not Documents ]]></title><description><![CDATA[As AI adoption accelerates in medical writing, many organizations fall into the trap of automating document-centric workflows without questioning the why behind these outputs. Here lies a regulatory paradox: documents don’t exist for their own sake—they exist to support decisions, satisfy regulatory intent, and ultimately impact patient health. Treating AI integration simply as a means to produce validated templates faster misses its true potential. The strategic fulcrum for AI’s...]]></description><link>https://www.synterex.com/post/regulatory-writing-ai-integration</link><guid isPermaLink="false">697795b4ea2eced60846062c</guid><category><![CDATA[Medical Writing & Pharma]]></category><pubDate>Mon, 26 Jan 2026 16:33:20 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/aab198_c0e65368e370430b9ae950583b89bd6a~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[Scaling Smarter: Strategies for Sustainable Growth]]></title><description><![CDATA[Join Synterex and Disability:In for "Scaling Smarter: Strategies for Sustainable Growth," a webinar on Feb. 18, at 12:00pm ET.]]></description><link>https://www.synterex.com/post/scaling-smarter-strategies-for-sustainable-growth</link><guid isPermaLink="false">6974028baffc20191ac59b1d</guid><category><![CDATA[Events]]></category><pubDate>Fri, 23 Jan 2026 23:23:57 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/e65684_2c827723d4294fb3b9ff48732553d935~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Synterex</dc:creator></item><item><title><![CDATA[FDA’s Flexible GMP Expectations for Cell and Gene Therapy: Innovation Accelerator or Deferred Risk? ]]></title><description><![CDATA[The FDA’s new announcement, Flexible Requirements for Cell and Gene Therapies to Advance Innovation , signals a notable shift in how regulators are thinking about manufacturing controls during early- and mid-stage development of cell and gene therapies (CGTs). The intent is clear: reduce unnecessary friction, lower barriers to clinical entry, and accelerate innovation for therapies often targeting serious or life-threatening diseases.  At the heart of the guidance are two statements that have...]]></description><link>https://www.synterex.com/post/fda-flexible-gmp-expectations</link><guid isPermaLink="false">6971b4f857bf74af131a558e</guid><category><![CDATA[Medical Writing & Pharma]]></category><category><![CDATA[Technology]]></category><pubDate>Thu, 22 Jan 2026 05:55:12 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/aab198_4c0adbe2a6384a1a97ec250f4a9c7981~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[Clinical Documentation Software Integration: Why “Plug-and-Play AI” Breaks Down in Clinical Writing Workflows ]]></title><description><![CDATA[In clinical documentation software integration, the promise of “plug-and-play AI” has become a siren’s call; just as it is said sailors were lured by the siren’s song only to encounter hidden dangers, clinical teams enticed by the promise of effortless AI integration often discover unforeseen complexities beneath the surface. Vendors often promise effortless automation and streamlined drafting powered by pretrained algorithms that can slot seamlessly into existing workflows—even in highly...]]></description><link>https://www.synterex.com/post/clinical-documentation-software-integration</link><guid isPermaLink="false">696975743e23fce29370aa4c</guid><category><![CDATA[Technology]]></category><category><![CDATA[Medical Writing & Pharma]]></category><category><![CDATA[Thought Leadership]]></category><pubDate>Tue, 20 Jan 2026 13:30:08 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/aab198_c56102a742134df7a3ec889c4e580057~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[The Hidden Cost of Manual Handoffs in AI-Assisted Writing: Clinical Documentation Bottlenecks ]]></title><description><![CDATA[The promise of AI-assisted writing in clinical documentation often evokes visions of blazing efficiency and seamless workflows. But beneath the surface lies a stubborn bottleneck that even the most sophisticated algorithms cannot erase: the manual handoffs between authors, reviewers, and disparate systems. This hidden friction point isn’t just a minor inconvenience; it is a systemic tax on time and quality that disrupts the very efficiencies AI aims to unlock and can lead to regulatory...]]></description><link>https://www.synterex.com/post/the-hidden-cost-of-manual-handoffs-in-ai-assisted-writing-clinical-documentation-bottlenecks</link><guid isPermaLink="false">69665a25e0a666a18e6a69a1</guid><category><![CDATA[Medical Writing & Pharma]]></category><category><![CDATA[Technology]]></category><pubDate>Tue, 13 Jan 2026 14:51:15 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/5bb25034a8bb415fb3d37edd270a7f96.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[Regulatory Writing, Spring ’26: Structured, Modular, and Ditching Fast Fashion ]]></title><description><![CDATA[Every year, regulatory writing gets a seasonal refresh. New tools, new terminology, new promises that this  is the year everything finally gets easier.  And yet.  In 2025, many teams were still relying on the same last-minute heroics, the same “we’ll fix it in review” optimism, and the same unspoken assumption that someone — a tool, a writer, a miracle — would make it all come together at the end.  In 2026, that illusion is finally wearing thin.  What’s changing isn’t the importance of...]]></description><link>https://www.synterex.com/post/regulatory-writing-spring-26</link><guid isPermaLink="false">695d2cb75194fa581889fc56</guid><category><![CDATA[Thought Leadership]]></category><pubDate>Tue, 06 Jan 2026 18:24:27 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/aab198_30a609e9efd64cc6b7a8bbc99f6f53e3~mv2.jpg/v1/fit/w_1000,h_571,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[RAG, CAG, and KAG—Oh My! A Medical Writer’s Journey Down the Yellow Brick Code ]]></title><description><![CDATA[Learn how RAG, CAG, and KAG enhance AI in medical writing by improving accuracy, consistency, and compliance. Discover where each fits in regulatory documentation and how Synterex supports explainable automation through AgileWriter.ai®.]]></description><link>https://www.synterex.com/post/rag-cag-kag-medical-writing</link><guid isPermaLink="false">6957f28162dea684c2ec24e3</guid><category><![CDATA[Medical Writing & Pharma]]></category><category><![CDATA[Technology]]></category><pubDate>Sat, 03 Jan 2026 01:20:30 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/aab198_b7af421d26fc4c57b62e4e6377b15747~mv2.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[What the FDA’s Innovation Push Reveals About Where Regulatory Systems Are Headed]]></title><description><![CDATA[The FDA’s latest innovation signals reveal how regulatory systems are evolving—and what FDA regulatory innovation may increasingly require from industry.]]></description><link>https://www.synterex.com/post/fda-innovation-push-signals-where-regulatory-systems-are-headed</link><guid isPermaLink="false">6949b554adc391625af7d2cd</guid><category><![CDATA[Medical Writing & Pharma]]></category><category><![CDATA[Technology]]></category><pubDate>Mon, 22 Dec 2025 22:42:04 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/e65684_d7fd554eb35e4a5599b8c20a22f8f101~mv2.png/v1/fit/w_1000,h_574,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[Anticipatory Design for Pre-Emptive Responses: How Regulatory Writers Can Think One Step Ahead ]]></title><description><![CDATA[Introduction: What Regulatory Writers Can Learn from UX   In user experience (UX) design, anticipatory design  refers to creating solutions before users even realize they need them. Think of it as removing friction by predicting needs and guiding users toward the right action at the right time.  For regulatory writers, the same principle applies: anticipate questions, concerns, and requests for clarification from reviewers before  they arise. This forward-thinking mindset improves document...]]></description><link>https://www.synterex.com/post/anticipatory-design-for-pre-emptive-responses</link><guid isPermaLink="false">6945da1bbb31a2c9401ae5fa</guid><category><![CDATA[Medical Writing & Pharma]]></category><pubDate>Sat, 20 Dec 2025 04:41:36 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/e65684_2c827723d4294fb3b9ff48732553d935~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[Synterex Joins the Veeva AI Product Partner Program to Accelerate Regulatory and Clinical Writing Efficiency and Compliance ]]></title><description><![CDATA[Dedham, MA — [ December 15, 2025 ] —  Synterex, a WBENC- and DOBE-certified consulting firm specializing in AI-enabled regulatory and clinical writing, announced that AgileWriter.ai®, the flagship module of the company’s AgileSuite™ digital regulatory ecosystem, has joined the Veeva AI Partner Program.  The collaboration will integrate AgileWriter with Veeva RIM, part of the Veeva Development Cloud—the technology foundation that streamlines data and processes across clinical, regulatory, and...]]></description><link>https://www.synterex.com/post/synterex-joins-the-veeva-ai-product-partner</link><guid isPermaLink="false">694066c624d4646829ca1c59</guid><category><![CDATA[Biotechnology]]></category><pubDate>Mon, 15 Dec 2025 20:09:46 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/d8dfee_b6d11138dbb14b868b38fe7136fd7186~mv2.png/v1/fit/w_505,h_352,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Synterex</dc:creator></item><item><title><![CDATA[FDA Eyes Single-Trial Approvals. The Race to Automate Just Went Critical. ]]></title><description><![CDATA[The FDA’s move toward single-trial approvals raises the stakes for every pivotal clinical trial. Learn how AI-driven documentation helps teams accelerate and stay compliant.]]></description><link>https://www.synterex.com/post/fda-eyes-single-trial-approvals-the-race-to-automate-just-went-critical</link><guid isPermaLink="false">6936de582f770d34a0b9b53d</guid><category><![CDATA[Medical Writing & Pharma]]></category><pubDate>Mon, 08 Dec 2025 14:55:17 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/5bb25034a8bb415fb3d37edd270a7f96.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[Runway Extended: How AI-Powered Regulatory Documentation Accelerates Approvals and Mitigates Risk ]]></title><description><![CDATA[In today’s high-stakes biopharma environment, speed, compliance, and precision define success. For regulatory and medical-writing teams, optimizing submission-ready content is no longer just operational—it’s strategic. With AI-powered regulatory documentation systems, companies can align earlier with submission requirements, anticipate reviewer expectations, and dramatically reduce rework and costly delays. The result: accelerated approvals, extended runway, and preserved opportunity.  The...]]></description><link>https://www.synterex.com/post/ai-powered-regulatory-documentation-accelerates-approvals-and-mitigates-risk</link><guid isPermaLink="false">693340376f872a8bb4d7e5cf</guid><category><![CDATA[Medical Writing & Pharma]]></category><category><![CDATA[Technology]]></category><pubDate>Fri, 05 Dec 2025 21:26:02 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/11062b_2358e90f5bca4049b0a219ebeeee8147~mv2.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[National Priority Vouchers: What They Signal—and How Sponsors Can Get Ready ]]></title><description><![CDATA[TL;DR: FDA’s new Commissioner’s National Priority Voucher (CNPV) program  accelerates reviews to ~1–2 months for products that advance U.S. national priorities: big-burden diseases, public-health crises, affordability, and on-shored manufacturing. If you’re heading into this pathway, success hinges on early CMC and labeling completeness, disciplined traceability, and an operating model built for rapid, team-based review.   What’s inside the program  Why it exists:  Speed access to therapies...]]></description><link>https://www.synterex.com/post/national-priority-vouchers-what-they-signal-and-how-sponsors-can-get-ready</link><guid isPermaLink="false">69279127d6cfa96de9e9ec4f</guid><category><![CDATA[Medical Writing & Pharma]]></category><pubDate>Thu, 27 Nov 2025 00:20:57 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/e65684_5782c9cb072047049ba8a1a268475fa9~mv2.png/v1/fit/w_1000,h_768,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[Synterex Launches AgileWriter.ai® on Microsoft Azure Marketplace to Accelerate Compliant Submissions for Life Sciences ]]></title><description><![CDATA[Azure-hosted AI platform revolutionizes clinical and regulatory writing with automation, traceability, and explainable AI.  Dedham, MA — November 21, 2025 — Synterex, Inc. , a global c onsulting firm specializing in clinical and regulatory operations, agile methodologies, and AI-driven technologies, has announced the availability of its flagship solution, AgileWriter.ai® , on the Microsoft Azure Marketplace. This launch expands access to Synterex’s AI-powered regulatory-writing platform for...]]></description><link>https://www.synterex.com/post/agilewriter-ai-on-microsoft-azure-marketplace</link><guid isPermaLink="false">6920d5884380ae0a508d936d</guid><category><![CDATA[Company News]]></category><pubDate>Fri, 21 Nov 2025 21:43:13 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/e65684_2c827723d4294fb3b9ff48732553d935~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Synterex</dc:creator></item><item><title><![CDATA[Fasten Your Seatbelts: Machine Learning Is Revolutionizing Clinical Trials ]]></title><description><![CDATA[Machine learning is transforming clinical trial monitoring from slow, manual oversight into real-time, predictive decision-making. As decentralized designs, digital biomarkers, and regulatory expectations evolve, the industry is entering a new era where data integrity, responsiveness, and automation are no longer optional—they’re essential.]]></description><link>https://www.synterex.com/post/fasten-your-seatbelts-machine-learning-is-revolutionizing-clinical-trials</link><guid isPermaLink="false">691b3cf2ee05004c7b8913b2</guid><category><![CDATA[Medical Writing & Pharma]]></category><pubDate>Mon, 17 Nov 2025 19:23:36 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/e65684_2c827723d4294fb3b9ff48732553d935~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Dora Miedaner</dc:creator></item><item><title><![CDATA[When the Regulator Becomes the Data Platform: How 2025 Real-World Evidence (RWE) Initiatives Are Rewriting Regulatory Review ]]></title><description><![CDATA[Discover how EMA and FDA are transforming from reviewers to data-platform operators—and how sponsors and writers must adapt to real-time evidence exchange and continuous review.]]></description><link>https://www.synterex.com/post/when-regulator-becomes-data-platform-rwe-regulatory-review-2025</link><guid isPermaLink="false">69091a081d235de50436baea</guid><category><![CDATA[Medical Writing & Pharma]]></category><category><![CDATA[Technology]]></category><pubDate>Mon, 03 Nov 2025 21:18:01 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/11062b_98ffac2531064322b00c756aa524dc97~mv2.jpeg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item><item><title><![CDATA[From Datasets to Disclosures: How the EU’s 2025 Real-World Evidence (RWE) Roadmap is Redefining Regulatory Writing ]]></title><description><![CDATA[Explore how the EMA’s 2025 Real-World Evidence Framework is reshaping regulatory submissions—and what it means for medical writers navigating structured data and evolving reviewer expectations.]]></description><link>https://www.synterex.com/post/from-datasets-to-disclosures-eu-2025-rwe-roadmap</link><guid isPermaLink="false">690907d312b86a0f317e4735</guid><category><![CDATA[Medical Writing & Pharma]]></category><category><![CDATA[Thought Leadership]]></category><pubDate>Mon, 03 Nov 2025 20:05:13 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8b068dde808f47ae820139c6af582e3d.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Jeanette Towles</dc:creator></item></channel></rss>